CYTK

CYTK

USD

Cytokinetics Incorporated Common Stock

$61.480+1.180 (1.957%)

वास्तविक समय मूल्य

Healthcare
जैव प्रौद्योगिकी
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$60.300

उच्च

$61.480

कम

$60.010

मात्रा

1.92M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

7.5B

उद्योग

जैव प्रौद्योगिकी

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

2.29M

एक्सचेंज

NMS

मुद्रा

USD

52-सप्ताह रेंज

कम $29.31वर्तमान $61.480उच्च $64.13

संबंधित समाचार

Analyst Upgrades

B. Riley Securities Reiterates Buy on Cytokinetics, Raises Price Target to $90

B. Riley Securities analyst Mayank Mamtani reiterates Cytokinetics with a Buy and raises the price target from $80 to $90.

और देखें
B. Riley Securities Reiterates Buy on Cytokinetics, Raises Price Target to $90
PR Newswire

Investors in Cytokinetics, Incorporated Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK

The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK). Shareholders who purchased shares of...

और देखें
Investors in Cytokinetics, Incorporated Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK
GlobeNewswire

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers SOUTH SAN FRANCISCO, Calif., Nov. 10, 2025 (GLOBE

और देखें
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
PR Newswire

CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27,...

और देखें
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
PR Newswire

CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27,...

और देखें
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
GlobeNewswire

Cytokinetics to Participate in November Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that members of the Company management team will participate in the following investor conferences

PR Newswire

Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।